Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWSulfanilamide is a sulfonamide antibiotic.1 It is bacteriostatic against Streptococcus when used at a concentration of 20 μg/ml and inhibits the growth of 106 clinical isolates of Gonococcus at 0.01% v/v.1,2 Sulfanilamide reduces plasma levels of Streptococcus in infected rabbits.3 It is an inhibitor of carbonic anhydrase II (CAII) and CAIX (Kis = 294 and 300 nM, respectively, for the human enzymes).4 It is selective for CAII and CAIX over CAI and CAIV (Kis = 3000 and >10,000 nM, respectively, for the bovine and human enzymes). Sulfanilamide inhibits the growth of S. haemolyticus and E. coli when used at a concentration of 300 µM.5 Formulations containing sulfanilamide have been used in the topical treatment of vaginal fungal infections.
WARNING This product is not for human or veterinary use.
1. The bactericidal effect of sulfanilamide upon beta hemolytic streptococci in vitro. J. Bacteriol. 36(5), 481-498 (1938).
2. The "Sulfanilamide Death Time" in vitro of 106 strains of the Gonococcus. J. Bacteriol. 41(4), 473-478 (1941).
3. On the mode of action of sulfanilamide in experimental streptococcus empyema. J. Exp. Med. 66(5), 535-548 (1937).
4. Carbonic anhydrase inhibitors: Inhibition of the tumor-
5. The biochemical specificity of sulfanilamide and of other antibacterial agents. Science 95(2472), 509-511 (1942).